Fennec Pharmaceuticals Inc.
FRX.TO
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 77.20% | 38.12% | -45.57% | -56.55% | -55.70% |
| Total Receivables | 21.45% | 80.23% | 49.85% | 42.15% | 50.36% |
| Inventory | 32.19% | 47.64% | 120.18% | 2.66% | -31.98% |
| Prepaid Expenses | 41.61% | 21.36% | -54.37% | -67.55% | -45.54% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 161.16% | 271.46% | 64.47% | 240.99% | 523.60% |
| Total Current Assets | 55.63% | 51.94% | -20.53% | -34.39% | -36.96% |
|
|
|||||
| Total Current Assets | 55.63% | 51.94% | -20.53% | -34.39% | -36.96% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 44.17% | 326.76% | 234.41% | 312.74% | 235.42% |
| Total Assets | 54.78% | 56.97% | -16.39% | -28.95% | -32.94% |
|
|
|||||
| Total Accounts Payable | 18.96% | 43.01% | 51.69% | 33.60% | 1.46% |
| Total Accrued Expenses | 7.53% | 64.38% | 11.71% | -26.76% | -34.84% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 0.00% | 0.00% | 0.00% | -1.59% | -1.59% |
| Total Other Current Liabilities | 0.00% | 0.00% | 0.00% | -1.59% | -1.59% |
| Total Current Liabilities | 14.51% | 52.02% | 32.01% | 8.58% | -14.89% |
|
|
|||||
| Total Current Liabilities | 14.51% | 52.02% | 32.01% | 8.58% | -14.89% |
| Long-Term Debt | -- | -- | -39.63% | -39.06% | -38.27% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | 0.00% | -1.73% | -1.73% |
| Total Liabilities | -34.69% | -30.97% | -16.13% | -18.88% | -21.00% |
|
|
|||||
| Common Stock & APIC | 24.30% | 24.03% | 3.61% | 2.83% | 2.66% |
| Retained Earnings | -3.79% | -4.43% | -3.19% | -5.68% | -6.99% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | 740.73% | 704.09% | 13.13% | -449.96% | -295.09% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 740.73% | 704.09% | 13.13% | -449.96% | -295.09% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 740.73% | 704.09% | 13.13% | -449.96% | -295.09% |
|
|
|||||